Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Flexible pain relief with morphine-free poppy

23.09.2004


Morphine-free poppy



A handful of genes in a morphine free poppy could hold the key to producing improved pain management pharmaceuticals. Norman, the ’no-morphine’ poppy, is superior to morphine producing poppies as it produces thebaine and oripavine – compounds preferred by industry in the manufacture of alternative high value pain-killers.

CSIRO’s Dr Phil Larkin, and The Australian National University’s Anthony Millgate and Dr Barry Pogson have been working with Tasmanian Alkaloids to investigate Norman the morphine-free poppy. "The genes we found behaved differently in Norman compared to standard morphine producing poppies and were consistently associated with the blockage in morphine synthesis and with the accumulation of thebaine and oripavine," Dr Larkin says.


"Understanding the genes responsible for the production of morphine, thebaine and oripavine is an important step in further developing poppies that are tailored to produce alternative pharmaceuticals."

The morphine free poppy variant, TOP1, was first discovered in 1995 by Tasmanian Alkaloids then released as Norman for commercial production in 1997 in Tasmania where it is now widely grown. "Norman created substantial industry growth when there was a surplus of traditional products, such as morphine, allowing us to supply raw materials for the manufacture of other pharmaceutical ingredients," says Tasmanian Alkaloids’ Manager of Agricultural Research, Dr Tony Fist.

Tasmania already grows over 40 per cent of the world’s legal poppy crops and Norman will ensure Tasmania stays an international leader in pharmaceutical development from poppy compounds.

This research is supported by voluntary contributions from industry with matched funding for R&D from the Australian Government through HAL and is a collaboration between CSIRO Plant Industry, The Australian National University, Tasmanian Alkaloids, Institute for Plant Biochemistry (Germany) and the University Halle (Germany).

Sophie Clayton | EurekAlert!
Further information:
http://www.csiro.au

More articles from Life Sciences:

nachricht During HIV infection, antibody can block B cells from fighting pathogens
14.08.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht First study on physical properties of giant cancer cells may inform new treatments
14.08.2018 | Brown University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

'Building up' stretchable electronics to be as multipurpose as your smartphone

14.08.2018 | Information Technology

During HIV infection, antibody can block B cells from fighting pathogens

14.08.2018 | Life Sciences

First study on physical properties of giant cancer cells may inform new treatments

14.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>